-logo-1200x675.png?v=20231006062033){kind=logo}
Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report)’s share price was up 7.8% during trading on Wednesday. The stock traded as high as $10.2450 and last traded at $10.2450. Approximately 100 shares were traded during mid-day trading, a decline of 93% from the average session volume of 1,536 shares. The stock had previously closed at $9.50.
Vitrolife AB (publ) Price Performance
The firm’s 50 day moving average is $9.53 and its two-hundred day moving average is $10.22.
About Vitrolife AB (publ)
Vitrolife AB (publ) is a Sweden-based medical technology company focused on assisted reproductive technology (ART) and fertility care. The company develops, manufactures and sells products and services used by fertility clinics, IVF laboratories and research institutions to support the handling, assessment, culture and preservation of human embryos and reproductive cells.
Its portfolio includes embryo culture media, laboratory consumables, cryopreservation solutions, micromanipulation equipment and time-lapse imaging systems, including the EmbryoScope platform.
See Also
- Five stocks we like better than Vitrolife AB (publ)
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
